BATS BZX Real-Time Price
As of 3:51pm ET
| +1.75 / +1.28%|
The 23 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 164.00, with a high estimate of 201.00 and a low estimate of 135.00. The median estimate represents a +18.68% increase from the last price of 138.19.
The current consensus among 27 polled investment analysts is to Buy stock in Abbvie Inc. This rating has held steady since May, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.